The First Lady of Lagos State, Dr. Mrs. Claudiana Ibijoke Sanwo-Olu, has reaffirmed the state government’s commitment to safeguarding children’s health as she flagged off the National Immunisation Plus Days (NIPD) at Epe Local Government Area.
Speaking at the state-wide launch, Dr. Sanwo-Olu, represented by Mrs. Oluwatoyin Badejo, emphasised the crucial role of immunisation in protecting children from life-threatening but preventable diseases such as polio and measles
She called on religious leaders, traditional rulers, and community-based organisations to intensify sensitisation efforts within their communities, ensuring that caregivers understand the importance of vaccinating all eligible children, especially those under five.
The First Lady also appealed to parents to grant consent for health workers to vaccinate children in schools, noting that this would help expand coverage and ensure no child is left behind.
“We must sustain and surpass the success recorded during the first round of this campaign. Every child deserves a healthy start to life, and immunisation remains one of the most cost-effective ways to protect them,” Dr. Sanwo-Olu urged.
Dr. Monsurat Adeleke, the Permanent Secretary of Health District III, the host district for the flag off, said that the renewed drive aligns with the health agenda of Governor Babajide Sanwo-Olu’s administration, which prioritises universal access to quality healthcare and the protection of vulnerable populations, particularly children.
According to her, the National Immunisation Plus Days is a nationwide initiative aimed at boosting immunity among children and eradicating vaccine-preventable diseases in Nigeria.
She assured that the Lagos State Government will continue to demonstrate its commitment to building a healthier, more resilient state through preventive healthcare measures and active community engagement.
Among the vaccines to be administered during the campaign is the Human Papillomavirus (HPV) vaccine, targeting children under the age of nine, to protect them against cervical cancer and other HPV-related diseases.
0 Comments